These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27746582)

  • 41. Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease.
    Bukovsky AA; Dorfman T; Weimann A; Göttlinger HG
    J Virol; 1997 Feb; 71(2):1013-8. PubMed ID: 8995620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1.
    Willey RL; Martin MA; Peden KW
    J Virol; 1994 Feb; 68(2):1029-39. PubMed ID: 7904656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions.
    Akari H; Fukumori T; Adachi A
    J Virol; 2000 May; 74(10):4891-3. PubMed ID: 10775630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions.
    Dettenhofer M; Yu XF
    J Virol; 1999 Feb; 73(2):1460-7. PubMed ID: 9882352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stimulated Emission Depletion Nanoscopy Reveals Time-Course of Human Immunodeficiency Virus Proteolytic Maturation.
    Hanne J; Göttfert F; Schimer J; Anders-Össwein M; Konvalinka J; Engelhardt J; Müller B; Hell SW; Kräusslich HG
    ACS Nano; 2016 Sep; 10(9):8215-22. PubMed ID: 27517329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
    Kiernan RE; Ono A; Englund G; Freed EO
    J Virol; 1998 May; 72(5):4116-26. PubMed ID: 9557701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment.
    Khan M; Jin L; Huang MB; Miles L; Bond VC; Powell MD
    J Virol; 2004 Feb; 78(4):1843-50. PubMed ID: 14747548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity.
    Day JR; Münk C; Guatelli JC
    J Virol; 2004 Feb; 78(3):1069-79. PubMed ID: 14722262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional Mapping of Regions Involved in the Negative Imprinting of Virion Particle Infectivity and in Target Cell Protection by Interferon-Induced Transmembrane Protein 3 against HIV-1.
    Appourchaux R; Delpeuch M; Zhong L; Burlaud-Gaillard J; Tartour K; Savidis G; Brass A; Etienne L; Roingeard P; Cimarelli A
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimal region sufficient for genome dimerization in the human immunodeficiency virus type 1 virion and its potential roles in the early stages of viral replication.
    Sakuragi J; Sakuragi S; Shioda T
    J Virol; 2007 Aug; 81(15):7985-92. PubMed ID: 17507464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Packageable antiviral therapeutics against human immunodeficiency virus type 1: virion-targeted virus inactivation by incorporation of a single-chain antibody against viral integrase into progeny virions.
    Okui N; Sakuma R; Kobayashi N; Yoshikura H; Kitamura T; Chiba J; Kitamura Y
    Hum Gene Ther; 2000 Mar; 11(4):537-46. PubMed ID: 10724032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exocytosis of Alphaherpesvirus Virions, Light Particles, and Glycoproteins Uses Constitutive Secretory Mechanisms.
    Hogue IB; Scherer J; Enquist LW
    mBio; 2016 Jun; 7(3):. PubMed ID: 27273828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization.
    Hioe CE; Bastiani L; Hildreth JE; Zolla-Pazner S
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S247-54. PubMed ID: 9814951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Virion-incorporated alpha-enolase suppresses the early stage of HIV-1 reverse transcription.
    Kishimoto N; Iga N; Yamamoto K; Takamune N; Misumi S
    Biochem Biophys Res Commun; 2017 Mar; 484(2):278-284. PubMed ID: 28115157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail.
    Wyma DJ; Jiang J; Shi J; Zhou J; Lineberger JE; Miller MD; Aiken C
    J Virol; 2004 Apr; 78(7):3429-35. PubMed ID: 15016865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression and incorporation of GagPol precursor does not impede packaging of HIV-1 tRNA(Lys3) but promotes intracellular budding of virus-like particles.
    Shehu-Xhilaga M; Lee JY; Campbell S; Marshall JA; Crowe SM; Mak J
    J Biomed Sci; 2002; 9(6 Pt 2):697-705. PubMed ID: 12432236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Collective properties of viral infectivity.
    Sanjuán R
    Curr Opin Virol; 2018 Dec; 33():1-6. PubMed ID: 30015082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity.
    Trkola A; Gordon C; Matthews J; Maxwell E; Ketas T; Czaplewski L; Proudfoot AE; Moore JP
    J Virol; 1999 Aug; 73(8):6370-9. PubMed ID: 10400729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.